Solving Kids' Cancer UK supports groundbreaking ITCC Scientific Days Conference
Research Manager, Stephanie Restivo, recounts her time at the ITCC Scientific Days Conference.
Charities come together for Teenage and Young Adult Cancer Awareness Month this April
April is Teenage and Young Adult Cancer Awareness Month (TYACAM) – an opportunity for charities and the young people we support to come together and raise awareness of the unique set of challenges facing this age group after being told they have cancer.
Solving Kids’ Cancer UK launches Development Board to grow fundraising and strengthen community support
We’re excited to announce the launch of our new Development Board, a strategic initiative aimed at strengthening our fundraising efforts and expanding support for our work.
The impact of charity funded research: Spotlight on the MiNivAn study
Charity-funded research plays a key role in advancing new treatments for children with cancer. In this blog, we shine a spotlight on the MiNivAn trial, a pioneering project in our research portfolio.
Solving Kids’ Cancer UK’s Chair of Trustees awarded MBE
Chair of Trustees, Nick Bird, has been awarded an MBE in the 2025 New Year Honours list for his exceptional services to research and advocacy for children affected by neuroblastoma.
Our Response to the NHS 10-Year Health Plan Consultation
As the government prepares it's 10 Year Health Plan, Solving Kids' Cancer has taken the opportunity to highlight the needs of children with cancer that must be recognised.
Meet the Thuraisingham Family: How Solving Kids’ Cancer UK’s Supporters Make a Difference
The neuroblastoma community plays a crucial role in raising awareness and generating much-needed funds for Solving Kids' Cancer UK.
Solving Kids' Cancer UK at the 2024 Party Conferences
This year we made our debut visit to the Labour and Conservative Party Conferences. Public Affairs & Advocacy Lead, Emily, reflects on the experience.
AMXT1501/DFMO (polyamine inhibition) therapy
AMXT1501/DFMO (polyamine inhibition) therapy
